Ingredient · Evidence grade C
Pycnogenol (pine bark) for menopause: evidence, studies and safety
Last updated · 2 studies summarized
C Short answer: Pycnogenol, a French maritime pine bark extract, has been studied in three controlled trials for occasional hot flashes and sleep problems in perimenopause*.
Key facts
| Evidence grade | C C |
|---|---|
| Use studied | climacteric symptoms |
| Trials | 3 placebo/controlled RCTs (n=170, ~200, 38) |
| Participants | ~400 |
| What reviews conclude | Cochrane 2020 (pine bark, chronic disorders) did not include menopause and found low-quality evidence overall. |
| The Menopause Society (2023) | Not assessed. |
| Also known as | French maritime pine bark, Pinus pinaster, Oligopin |
Grades: A strong · B moderate · C limited · D none or negative. How we grade.
Every study we reviewed
Each summary gives who took part, the dose, how long, the result compared with placebo or control, and who paid for it.
-
Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial.
170 Japanese women took a low dose of French maritime pine bark extract (60 mg a day) or placebo for 12 weeks. Symptoms, especially hot flashes and sleep, improved more than placebo, though placebo also helped a lot.
- Who
- 170 perimenopausal women (Japan)
- Dose
- Pycnogenol 30 mg twice daily
- Duration
- 12 weeks
- Result
- Kupperman -56% vs -39% placebo (P<.05); hot flashes and sleep improved.
- Funding
- Not stated in abstract (Horphag Research, maker, typically supports Pycnogenol trials; not verified). Funding not stated
-
A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women.
About 200 Taiwanese women took 200 mg pine bark extract or placebo for 6 months, and symptoms improved more with the extract.
- Who
- 200 enrolled, 155 completed (Taiwan)
- Dose
- Pycnogenol 200 mg/day
- Duration
- 6 months
- Result
- All climacteric symptoms improved vs placebo; antioxidant status improved.
- Funding
- Not stated in abstract. Funding not stated
Safety
Well tolerated in trials.
Ranked products that contain it
| Product | Amount per day | Score | $/day |
|---|---|---|---|
| Kindra MenoRelief | Pycnogenol French maritime pine bark extract: 100 mg | 48.1 | $1.30 |
| Womaness Me.No.Pause. | Pycnogenol pine bark extract: 60 mg | 40.6 | $1.57 |
FAQ
Does Pycnogenol (pine bark) help with menopause symptoms?
Pycnogenol, a French maritime pine bark extract, has been studied in three controlled trials for occasional hot flashes and sleep problems in perimenopause*. Our evidence grade is C. Cochrane 2020 (pine bark, chronic disorders) did not include menopause and found low-quality evidence overall.
Does The Menopause Society recommend Pycnogenol (pine bark)?
Not assessed. The 2023 nonhormone statement recommends no dietary supplement for hot flashes; talk to a clinician about hormone therapy and prescription options.
Is Pycnogenol (pine bark) safe?
Well tolerated in trials. Supplements are not FDA-approved before sale; ask a clinician or pharmacist, especially if you take medication.
Sources
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.